Navigation Links
Golden West Biologicals, Inc. and Sunfco, Ltd. Expand Sales of Vitamin D Free Human Serum in Japan
Date:7/26/2013

TEMECULA, Calif. and TOKYO, July 26, 2013 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. (GWB), a leading provider and manufacturer of diagnostic products and Sunfco, Ltd., a leading provider of raw material ingredients for food products, medicinal products, biotech products, health food products and other products in the fine chemicals field, today announced the rapid growth in sales of GWB's Mass Spect Gold® line of human serum in Japan.

(Photo: http://photos.prnewswire.com/prnh/20130726/MN54059)

"Our partnership with Sunfco has created a strong distribution channel for our Mass Spec Gold products," said Tammy Guenthner, Manufacturing Manager at GWB.  "Sunfco's deep knowledge of the diagnostics market in Japan has enabled us to dramatically increase our sales over last year."

GWB supplies Sunfco with a broad range of products used in the diagnostics industry.  After the United States and European Union, Japan is the World's 3rd largest In-Vitro Diagnostics (IVD) market.  And due to demographic shifts in Japan, the industry is expected to show further growth.

About Golden West Biologicals, Inc.

Golden West Biologicals, Inc. (GWB) is a privately held company headquartered in Temecula, California.  The company was formed in 1989 to directly address the need for cost effective and technically superior biological raw materials for the development of immunoassays and LC-MS applications.  GWB provides manufacturers and laboratories with over 80 human and animal biological products including Vitamin D free human serum, human serum for ultra-sensitive testing, human serum albumin/gamma globulin, and rabbit gamma globulin.  Additional information, including the complete line of products, can be found at the company website www.goldenwestbio.com.

About Sunfco Ltd.

Sunfco Ltd. was established by the capital investments of Morinaga Milk Industry Co., Ltd., Taiyo Kagaku Co., Ltd., and Kaei Trading Co., Ltd. as "Sun Friend Chemical Ltd." on March 1, 1979.  Since its founding, the company has sought to supply and develop raw material ingredients and products for the benefit of its customers through a policy of honesty and integrity.

In September 1989, the company changed its name to "Sunfco Ltd." due to a healthy expansion of its business owing to the steady patronage of its valued customers.

Based on its ability to rapidly respond to the dramatic changes of our time, the company offers unique raw material ingredients for food products, medicinal products, biotech products, health food products and other products in the fine chemicals field as well as knowledge products (intermediary services for entrusting processing services) in advancing globalization and specialization.  Additional information, including the complete line of products, can be found at the company website www.sunfco.com.

Contact:
For more information:
Golden West Biologicals, Inc.
Ward Komers
Phone: 888-690-0963
info@goldenwestbio.com
www.goldenwestbio.com

Sunfco Ltd.
Shozo Shimada
1-8-3 Kaji-cho
Chiyoda-ku
Tokyo 101-0044 (Kanda91 Building 8F)
TEL:+011-813-3255-2460(Main)
FAX:+011-813-3255-0787
sshimada@sunfco.com
www.sunfco.com

Media Contact: Brian Golie, Golden West Biologicals, Inc., 951-699-0957, webmaster@goldenwestbio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Golden West Biologicals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Golden West Biologicals, Inc. Exhibiting at AACC Clinical Lab Expo 2013
2. China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
3. Golden potential for gold thin films
4. CellerateRX® Added to List of Preferred Products for Golden Living Healthcare Network
5. Tissue Culture Biologicals, Inc. Hires James D. Titus to Lead New Expansion and Branding Development Effort
6. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
7. Life Technologies Expands CEERAM Food Safety Range to Global Market
8. Cardno Expands to Include a New Business Line Focused on Health Sciences
9. Elliott Broidy Expands Role in Los Angeles Civics with Support of Stem Cell Research Program
10. Rare collection that may hold key to oceans biggest mysteries looks to expand in new waterfront home
11. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):